The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells

Eva Martínez-García(Northwestern University), Relja Popovic(Northwestern University), Dong Joon Min(Northwestern University), Steve M. M. Sweet(Northwestern University), Paul M. Thomas(Northwestern University), Leonid Zamdborg(Northwestern University), Aaron Heffner(National Cancer Institute), Christine Will(Northwestern University), Laurence Lamy(National Cancer Institute), Louis M. Staudt(National Cancer Institute), David Levens(National Cancer Institute), Neil L. Kelleher(Northwestern University), Jonathan D. Licht(Northwestern University)
Blood
October 26, 2010
Cited by 357Open Access
Full Text

Abstract

The multiple myeloma SET domain (MMSET) protein is overexpressed in multiple myeloma (MM) patients with the translocation t(4;14). Although studies have shown the involvement of MMSET/Wolf-Hirschhorn syndrome candidate 1 in development, its mode of action in the pathogenesis of MM is largely unknown. We found that MMSET is a major regulator of chromatin structure and transcription in t(4;14) MM cells. High levels of MMSET correlate with an increase in lysine 36 methylation of histone H3 and a decrease in lysine 27 methylation across the genome, leading to a more open structural state of the chromatin. Loss of MMSET expression alters adhesion properties, suppresses growth, and induces apoptosis in MM cells. Consequently, genes affected by high levels of MMSET are implicated in the p53 pathway, cell cycle regulation, and integrin signaling. Regulation of many of these genes required functional histone methyl-transferase activity of MMSET. These results implicate MMSET as a major epigenetic regulator in t(4;14)+ MM.


Related Papers

No related papers found

Powered by citation graph analysis